OR | 95% CI | P | |
---|---|---|---|
First step | |||
Midazolam (reference: no midazolam) | 0.805 | 0.140; 4.620 | 0.808 |
Year of enrollment (per year increase) | 0.823 | 0.438; 1.566 | 0.563 |
ORP (reference: RARP) | 1.163 | 0.595; 2.169 | 0.700 |
Age (per year increase) | 1.103 | 1.044; 1.164 | < 0.001 |
ASA physical status (reference: ASA III) | |||
ASA I | 0.872 | 0.435; 1.748 | 0.699 |
ASA II | 1.140 | 0.468; 2.776 | 0.772 |
Estimated blood loss (per ml increase) | 1.093 | 0.752; 1.588 | 0.642 |
Duration of surgery (per min increase) | 2.661 | 0.668; 10.597 | 0.165 |
Sufentanil (per μg kg−1 h−1 increase) | 1.010 | 0.996; 1.024 | 0.145 |
Final step | |||
Midazolam (reference: no midazolam) | 1.240 | 0.241; 6.386 | 0.797 |
Year of enrollment (per year increase) | 0.933 | 0.513; 1.695 | 0.819 |
Age (per year increase) | 1.100 | 1.043; 1.161 | < 0.001 |
Duration of surgery (per min increase) | 4.123 | 1.284; 13.241 | 0.017 |